Cargando…

Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers

Non-small cell lung cancers (NSCLCs) establish a highly immunosuppressive tumor microenvironment supporting cancer growth. To interfere with cancer-mediated immunosuppression, selective immune-checkpoint inhibitors (ICIs) have been approved as a standard-of-care treatment for NSCLCs. However, the ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masemann, Dörthe, Meissner, Ramona, Schied, Tanja, Lichty, Brian D, Rapp, Ulf R, Wixler, Viktor, Ludwig, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894418/ https://www.ncbi.nlm.nih.gov/pubmed/33643696 http://dx.doi.org/10.1080/2162402X.2021.1885778

Ejemplares similares

Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages
por: Masemann, Dörthe, et al.
Publicado: (2018)

PD-1 IC Inhibition Synergistically Improves Influenza A Virus-Mediated Oncolysis of Metastatic Pulmonary Melanoma
por: Sitnik, Siarhei, et al.
Publicado: (2020)

Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer
por: Meissner, Ramona, et al.
Publicado: (2023)

The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis
por: Alnajar, Abdulaleem, et al.
Publicado: (2013)

In Vitro and In Vivo Antitumor Activity of a Novel Semisynthetic Derivative of Cucurbitacin B
por: Silva, Izabella T., et al.
Publicado: (2015)

The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated with Specific Structures in the Nucleus
por: Nacken, Wolfgang, et al.
Publicado: (2021)

Advances in Transgenic Mouse Models to Study Infections by Human Pathogenic Viruses
por: Masemann, Dörthe, et al.
Publicado: (2020)

β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling
por: Hillesheim, Andrea, et al.
Publicado: (2014)

Oncolytic Viruses: Therapeutics With an Identity Crisis
por: Breitbach, Caroline J., et al.
Publicado: (2016)

The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model
por: Schloer, Sebastian, et al.
Publicado: (2019)

Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy
por: Marek, Janina, et al.
Publicado: (2023)

Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity
por: Kathum, Omer Abid, et al.
Publicado: (2016)

Doxycycline-Induced Expression of Transgenic Human Tumor Necrosis Factor α in Adult Mice Results in Psoriasis-like Arthritis
por: Retser, Eugen, et al.
Publicado: (2013)

Cell-intrinsic genomic reassortment of pandemic H1N1 2009 and Eurasian avian-like swine influenza viruses results in potentially zoonotic variants
por: Ferrando, Verónica A., et al.
Publicado: (2023)

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
por: Xie, Daoyuan, et al.
Publicado: (2023)

Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer
por: McGray, A. J. Robert, et al.
Publicado: (2019)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
por: Nelson, Adam, et al.
Publicado: (2022)

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
por: Oseledchyk, Anton, et al.
Publicado: (2018)

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade
por: Saha, Dipongkor, et al.
Publicado: (2017)

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018)

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
por: Sivanandam, Venkatesh, et al.
Publicado: (2019)

Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase
por: Kuznetsova, Irina, et al.
Publicado: (2017)

MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover
por: Spiering, Désirée, et al.
Publicado: (2009)

Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma
por: Xing, Fan, et al.
Publicado: (2021)

Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy
por: Li, Shuwen, et al.
Publicado: (2017)

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
por: Marchini, Antonio, et al.
Publicado: (2016)

Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
por: Hwang, June Kyu, et al.
Publicado: (2020)

Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
por: Lovatt, Charlotte, et al.
Publicado: (2023)

Development and applications of oncolytic Maraba virus vaccines
por: Pol, Jonathan G, et al.
Publicado: (2018)

A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
por: Schlerman, F, et al.
Publicado: (2013)

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
por: Roy, D. G., et al.
Publicado: (2021)

Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model
por: Friedman, Avner, et al.
Publicado: (2018)

Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccines
por: Bridle, Byram W, et al.
Publicado: (2013)

Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
por: Pol, Jonathan G, et al.
Publicado: (2020)

The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells
por: Bou-Hanna, Chantal, et al.
Publicado: (2018)

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth
por: Wu, Zhiwen, et al.
Publicado: (2019)

Interventional Optical Imaging-Monitored Synergistic Effect of Radio-Frequency Hyperthermia and Oncolytic Immunotherapy
por: Zheng, Hui, et al.
Publicado: (2022)

Combined oncolytic virotherapy gold nanoparticles as synergistic immunotherapy agent in breast cancer control
por: Jabir, Majid S., et al.
Publicado: (2023)

IC Reference
por: Dolmazon, Emeline
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_34qsldprq7gkt0rb6m8c556pu9